42 research outputs found
Visualizing Individual Nitrogen Dopants in Monolayer Graphene
In monolayer graphene, substitutional doping during growth can be used to
alter its electronic properties. We used scanning tunneling microscopy (STM),
Raman spectroscopy, x-ray spectroscopy, and first principles calculations to
characterize individual nitrogen dopants in monolayer graphene grown on a
copper substrate. Individual nitrogen atoms were incorporated as graphitic
dopants, and a fraction of the extra electron on each nitrogen atom was
delocalized into the graphene lattice. The electronic structure of
nitrogen-doped graphene was strongly modified only within a few lattice
spacings of the site of the nitrogen dopant. These findings show that chemical
doping is a promising route to achieving high-quality graphene films with a
large carrier concentration.Comment: Science 201
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
We retrospectively studied 181 patients with polycythaemia vera (n=67), essential thrombocythaemia (n=67) or primary myelofibrosis (n=47), who presented a first episode of splanchnic vein thrombosis (SVT). Budd-Chiari syndrome (BCS) and portal vein thrombosis were diagnosed in 31 (17.1%) and 109 (60.3%) patients, respectively; isolated thrombosis of the mesenteric or splenic veins was detected in 18 and 23 cases, respectively. After this index event, the patients were followed for 735 patient years (pt-years) and experienced 31 recurrences corresponding to an incidence rate of 4.2 per 100 pt-years. Factors associated with a significantly higher risk of recurrence were BCS (hazard ratio (HR): 3.03), history of previous thrombosis (HR: 3.62), splenomegaly (HR: 2.66) and leukocytosis (HR: 2.8). Vitamin K-antagonists (VKA) were prescribed in 85% of patients and the recurrence rate was 3.9 per 100 pt-years, whereas in the small fraction (15%) not receiving VKA more recurrences (7.2 per 100 pt-years) were reported. Intracranial and extracranial major bleeding was recorded mainly in patients on VKA and the corresponding rate was 2.0 per 100 pt-years. In conclusion, despite anticoagulation treatment, the recurrence rate after SVT in myeloproliferative neoplasms is high and suggests the exploration of new avenues of secondary prophylaxis with new antithrombotic drugs and JAK-2 inhibitors
Rapid Accumulation of CD14+CD11c+ Dendritic Cells in Gut Mucosa of Celiac Disease after in vivo Gluten Challenge
Of antigen-presenting cells (APCs) expressing HLA-DQ molecules in the celiac disease (CD) lesion, CD11c(+) dendritic cells (DCs) co-expressing the monocyte marker CD14 are increased, whereas other DC subsets (CD1c(+) or CD103(+)) and CD163(+)CD11c(-) macrophages are all decreased. It is unclear whether these changes result from chronic inflammation or whether they represent early events in the gluten response. We have addressed this in a model of in vivo gluten challenge.Treated HLA-DQ2(+) CD patients (n = 12) and HLA-DQ2(+) gluten-sensitive control subjects (n = 12) on a gluten-free diet (GFD) were orally challenged with gluten for three days. Duodenal biopsies obtained before and after gluten challenge were subjected to immunohistochemistry. Single cell digests of duodenal biopsies from healthy controls (n = 4), treated CD (n = 3) and untreated CD (n = 3) patients were analyzed by flow cytometry.In treated CD patients, the gluten challenge increased the density of CD14(+)CD11c(+) DCs, whereas the density of CD103(+)CD11c(+) DCs and CD163(+)CD11c(-) macrophages decreased, and the density of CD1c(+)CD11c(+) DCs remained unchanged. Most CD14(+)CD11c(+) DCs co-expressed CCR2. The density of neutrophils also increased in the challenged mucosa, but in most patients no architectural changes or increase of CD3(+) intraepithelial lymphocytes (IELs) were found. In control tissue no significant changes were observed.Rapid accumulation of CD14(+)CD11c(+) DCs is specific to CD and precedes changes in mucosal architecture, indicating that this DC subset may be directly involved in the immunopathology of the disease. The expression of CCR2 and CD14 on the accumulating CD11c(+) DCs indicates that these cells are newly recruited monocytes
Quantum criticality in ferroelectrics
Materials tuned to the neighbourhood of a zero temperature phase transition
often show the emergence of novel quantum phenomena. Much of the effort to
study these new effects, like the breakdown of the conventional Fermi-liquid
theory of metals has been focused in narrow band electronic systems.
Ferroelectric crystals provide a very different type of quantum criticality
that arises purely from the crystalline lattice. In many cases the
ferroelectric phase can be tuned to absolute zero using hydrostatic pressure or
chemical or isotopic substitution. Close to such a zero temperature phase
transition, the dielectric constant and other quantities change into radically
unconventional forms due to the quantum fluctuations of the electrical
polarization. The simplest ferroelectrics may form a text-book paradigm of
quantum criticality in the solid-state as the difficulties found in metals due
to a high density of gapless excitations on the Fermi surface are avoided. We
present low temperature high precision data demonstrating these effects in pure
single crystals of SrTiO3 and KTaO3. We outline a model for describing the
physics of ferroelectrics close to quantum criticality and highlight the
expected 1/T2 dependence of the dielectric constant measured over a wide
temperature range at low temperatures. In the neighbourhood of the quantum
critical point we report the emergence of a small frequency independent peak in
the dielectric constant at approximately 2K in SrTiO3 and 3K in KTaO3 believed
to arise from coupling to acoustic phonons. Looking ahead, we suggest that in
ferroelectric materials supporting mobile charge carriers, quantum paraelectric
fluctuations may mediate new effective electron-electron interactions giving
rise to a number of possible states such as superconductivity.Comment: 10 pages, 4 figure
Heat-Induced Structural Changes Affect OVA-Antigen Processing and Reduce Allergic Response in Mouse Model of Food Allergy
BACKGROUND AND AIMS: The egg protein ovalbumin (OVA) belongs to six most frequent food allergens. We investigated how thermal processing influences its ability to induce allergic symptoms and immune responses in mouse model of food allergy. METHODOLOGY/PRINCIPAL FINDINGS: Effect of increased temperature (70°C and 95°C) on OVA secondary structure was characterized by circular dichroism and by the kinetics of pepsin digestion with subsequent HPLC. BALB/c mice were sensitized intraperitoneally and challenged with repeated gavages of OVA or OVA heated to 70°C (h-OVA). Levels of allergen-specific serum antibodies were determined by ELISA (IgA and IgGs) or by β-hexosaminidase release test (IgE). Specific activities of digestive enzymes were determined in brush border membrane vesicles of jejunal enterocytes. Cytokine production and changes in regulatory T cells in mesenteric lymph nodes and spleen were assessed by ELISA and FACS. Heating of OVA to 70°C caused mild irreversible changes in secondary structure compared to boiling to 95°C (b-OVA), but both OVA treatments led to markedly different digestion kinetics and Tregs induction ability in vitro, compared to native OVA. Heating of OVA significantly decreased clinical symptoms (allergic diarrhea) and immune allergic response on the level of IgE, IL-4, IL-5, IL-13. Furthermore, h-OVA induced lower activities of serum mast cell protease-1 and enterocyte brush border membrane alkaline phosphatase as compared to native OVA. On the other hand h-OVA stimulated higher IgG2a in sera and IFN-γ secretion by splenocytes. CONCLUSIONS: Minor irreversible changes in OVA secondary structure caused by thermal processing changes both its digestion and antigenic epitopes formation, which leads to activation of different T cell subpopulations, induces shift towards Th1 response and ultimately reduces its allergenicity